Portola Pharma (PTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 9,625 | 10,531 | 72,042 | 78,029 | 35,268 |
| Gross Profit | 9,625 | 10,531 | 72,042 | 78,029 | 35,268 |
| Operating Expenses | 147,191 | 94,709 | 61,186 | 58,160 | 54,022 |
| Operating Income | -137,566 | -84,178 | 10,856 | 19,869 | -18,754 |
| Interest Expense | 0 | 0 | 0 | 21 | 380 |
| Other Income | 441 | 826 | 510 | 136 | 1,659 |
| Pre-tax Income | -137,125 | -83,352 | 11,366 | 19,984 | -17,475 |
| Income Tax | N/A | N/A | N/A | N/A | 2,794 |
| Net Income Continuous | -137,125 | -83,352 | 11,366 | 19,984 | -20,269 |
| Net Income | $-137,125 | $-83,352 | $11,366 | $19,984 | $-20,269 |
| EPS Basic Total Ops | -3.19 | -3.65 | 8.41 | 0.06 | -16.79 |
| EPS Basic Continuous Ops | -3.19 | -3.65 | 8.41 | 15.99 | -16.79 |
| EPS Diluted Total Ops | -3.19 | -3.65 | 5.55 | 0.06 | -16.79 |
| EPS Diluted Continuous Ops | -3.19 | -3.65 | 5.55 | 9.57 | -16.79 |
| EPS Diluted Before Non-Recurring Items | -3.19 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-132,321 | $-80,486 | $13,714 | $22,002 | $-17,201 |